Potency, efficacy and durability of DNA/DNA, DNA/protein and protein/protein based vaccination using gp63 against Leishmania donovani in BALB/c mice.
about
Possibilities and challenges for developing a successful vaccine for leishmaniasisPotentiating effects of MPL on DSPC bearing cationic liposomes promote recombinant GP63 vaccine efficacy: high immunogenicity and protectionImmunogenicity and Protective Efficacy of Brugia malayi Heavy Chain Myosin as Homologous DNA, Protein and Heterologous DNA/Protein Prime Boost Vaccine in Rodent ModelDNA-protein immunization using Leishmania peroxidoxin-1 induces a strong CD4+ T cell response and partially protects mice from cutaneous leishmaniasis: role of fusion murine granulocyte-macrophage colony-stimulating factor DNA adjuvantIdentifying vaccine targets for anti-leishmanial vaccine developmentVisceral Leishmaniasis: Advancements in Vaccine Development via Classical and Molecular ApproachesThe influence of delivery vectors on HIV vaccine efficacyProtective effect of a prime-boost strategy with the Ts87 vaccine against Trichinella spiralis infection in miceIdentification and characterization of paramyosin from cyst wall of metacercariae implicated protective efficacy against Clonorchis sinensis infection.A pilot study on developing mucosal vaccine against alveolar echinococcosis (AE) using recombinant tetraspanin 3: Vaccine efficacy and immunology.Vaccination with L. infantum chagasi nucleosomal histones confers protection against new world cutaneous leishmaniasis caused by Leishmania braziliensis.Molecular cloning and expression analysis of peptidase genes in the fish-pathogenic scuticociliate Miamiensis avidus.Mucosal application of gp140 encoding DNA polyplexes to different tissues results in altered immunological outcomes in mice.Development of Vaccines against Visceral LeishmaniasisAn overview on Leishmania vaccines: A narrative review article.The gp63 Gene Cluster Is Highly Polymorphic in Natural Leishmania (Viannia) braziliensis Populations, but Functional Sites Are Conserved.Noninvasive Diagnosis of Visceral Leishmaniasis: Development and Evaluation of Two Urine-Based Immunoassays for Detection of Leishmania donovani Infection in India.The future of human DNA vaccinesDevelopment of Leishmania vaccines: predicting the future from past and present experience.Vaccine Development Against Leishmania donovani.Protective immunity and vaccination against cutaneous leishmaniasis.DNA vaccine against visceral leishmaniasis: a promising approach for prevention and control.Immunogenicity and protective efficacy of DNA vaccine against visceral leishmaniasis in BALB/c miceA Lipid Based Antigen Delivery System Efficiently Facilitates MHC Class-I Antigen Presentation in Dendritic Cells to Stimulate CD8(+) T CellsHead-to-head comparison of three vaccination strategies based on DNA and raw insect-derived recombinant proteins against Leishmania.Saccharomyces boulardii ingestion increases the humoral response of a DNA vaccine against leptospirosis in mice.Immune Response and Protective Efficacy of a Heterologous DNA-Protein Immunization with Leishmania Superoxide Dismutase B1.Liposomal Elongation Factor-1α Triggers Effector CD4 and CD8 T Cells for Induction of Long-Lasting Protective Immunity against Visceral Leishmaniasis.Alternative to Chemotherapy-The Unmet Demand against Leishmaniasis.Immunoproteomic Identification and Characterization of Leishmania Membrane Proteins as Non-Invasive Diagnostic Candidates for Clinical Visceral Leishmaniasis
P2860
Q26749758-92BCABEA-4CD7-4EDE-B04B-4F084B95F3DAQ27305883-A5BD40AC-EB1C-4AA5-BD84-75344E6578BEQ27345320-399DB683-288C-4885-9D2B-9760E0132D4BQ28542668-1808F6AD-0915-44FC-8CEC-570C85617B01Q33693899-58248CE3-FE1F-4EF6-9810-A79FD715A158Q34076804-F9DF775E-451D-4923-A564-96FD5F203516Q34077543-6480CD6F-C17D-41D3-8BD9-7E5277D7690FQ34183489-F9A84FAF-C425-46FD-9825-D5729AEB07FCQ34217433-FE3A8464-9061-4EA1-9221-AB24E6EFEDADQ34222728-9AA128B2-F013-47D9-B9D2-6DCC76FE7572Q34533591-36F4DD6F-5FD7-4821-9DFB-F6CCB4B764F2Q34545937-3EBF9DF9-3A52-47CD-BFE8-F44B8FDF362EQ34797176-34968EDF-F937-4A32-AFE4-582B73D723D0Q35207606-8C9F2B0F-4A86-40EF-92A6-0049F4B2FE0BQ35517074-14308D5B-5643-49F3-ABE1-FE8D01B5DD01Q36138192-986D906F-3309-4AA9-9916-212FE4251D3DQ36163680-E23E1D94-2367-4119-B310-3A134DAB65AEQ36438236-753970AA-0257-48EE-BE80-F87704C0FEB0Q36700453-4C68C083-29C1-43DA-A687-0814BCDB3CE0Q38012112-1BE50FE4-5878-4391-A81C-B71D3BE9EA99Q38015852-EDC08CE2-28A9-4AC4-B979-A386CB2C1B3FQ38786910-CAABD2B6-E0BC-4B65-B75D-E82F529CD2B4Q40572422-560DAF5C-F2C1-4C66-AEAC-F67F246D8E0EQ40649527-B66FB953-1F7E-453B-BA73-72828D7D8AD0Q41404819-03514599-4792-40D3-82C0-90B936ADD7A5Q46675427-C092DC54-BD0D-4AC8-8BCB-164814825E2CQ48189111-B079D3DF-BE6A-4C37-84A9-91538A633E0BQ49210114-A58F7C68-A08A-4A4F-A5F2-34439C9B3E7FQ50130388-88875DDB-C1C0-448F-8D9C-A4E658D180B1Q57929764-01CC16D2-80E6-42AE-8809-FA5ECA644CEA
P2860
Potency, efficacy and durability of DNA/DNA, DNA/protein and protein/protein based vaccination using gp63 against Leishmania donovani in BALB/c mice.
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Potency, efficacy and durabili ...... mania donovani in BALB/c mice.
@ast
Potency, efficacy and durabili ...... mania donovani in BALB/c mice.
@en
type
label
Potency, efficacy and durabili ...... mania donovani in BALB/c mice.
@ast
Potency, efficacy and durabili ...... mania donovani in BALB/c mice.
@en
prefLabel
Potency, efficacy and durabili ...... mania donovani in BALB/c mice.
@ast
Potency, efficacy and durabili ...... mania donovani in BALB/c mice.
@en
P2093
P2860
P1433
P1476
Potency, efficacy and durabili ...... mania donovani in BALB/c mice.
@en
P2093
Amrita Das
Mithun Maji
Saumyabrata Mazumder
P2860
P304
P356
10.1371/JOURNAL.PONE.0014644
P407
P577
2011-02-02T00:00:00Z